Evidence map›Paper›PMID 40194754›Full record

ArticleBiological psychiatry2026

Noradrenaline Modulates Central Amygdala GABA Transmission and Alcohol Drinking in Female Rats.

Alexia Anjos-Santos, Chloe Michelle Erikson, Francisco J Flores-Ramirez, Larry Rodriguez, Riccardo Barchiesi, Valentina Vozella, Vittoria Borgonetti, Bryan Cruz, Cristina Zalfa, Kiley Hughes and 6 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alexia Anjos-SantosDepartment of Translational Medicine, Scripps Research, La Jolla, California; Department of Pharmacology, Universidade Federal de São Paulo, São Paulo, Brazil.
Chloe Michelle EriksonDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Francisco J Flores-RamirezDepartment of Translational Medicine, Scripps Research, La Jolla, California; Department of Psychology, California State University, San Marcos, San Marcos, California.
Larry RodriguezDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Riccardo BarchiesiDepartment of Neuroscience, University of Texas at Austin, Austin, Texas; Waggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, Texas.
Valentina VozellaDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Vittoria BorgonettiDepartment of Translational Medicine, Scripps Research, La Jolla, California; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Bryan CruzDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Cristina ZalfaDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Kiley HughesDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Pauravi GandhiDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Michal BajoDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Roman VlkolinskyDepartment of Translational Medicine, Scripps Research, La Jolla, California.
R Dayne MayfieldDepartment of Neuroscience, University of Texas at Austin, Austin, Texas; Waggoner Center for Alcohol and Addiction Research, University of Texas at Austin, Austin, Texas.
Rémi Martin-FardonDepartment of Translational Medicine, Scripps Research, La Jolla, California.
Marisa RobertoDepartment of Translational Medicine, Scripps Research, La Jolla, California. Electronic address: mroberto@scripps.edu.

Funding

Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI AMANDA J ROBERTS · 2003 to 2026
$46.3M
Neurpsychopharmacology-Multidisciplinary TrainingT32AA007456 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 1985 to 2026
$13.4M
Electrophysiology of alcohol in extended amygdelaU01AA013498 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 2001 to 2026
$12.6M
GENE EXPRESSION IN THE HUMAN ALCOHOLIC BRAINR01AA012404 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI MAYFIELD, ROY DAYNE · 2000 to 2025
$10.7M
Next Generation Sequencing of Human Alcoholic BrainU01AA020926 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI Roy DAYNE MAYFIELD · 2011 to 2026
$6.7M
Neuroplasticity of the Extended Amygdala CRF circuitry in alcohol dependenceR01AA021491 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2013 to 2024
$3.9M
Gene-environment interaction: the brain CRF system in alcohol preferring msP ratsR37AA017447 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2016 to 2025
$3.7M
Drug targeting the dynamics of opioid systems in alcohol dependenceR01AA028549 · NIAAA · KAROLINSKA INSTITUTE · PI MARTIN-FARDON, REMI, TALISMAN, TIJANA · 2020 to 2024
$2.6M
Neuroimmune mechanisms in stress and alcohol comorbidityR01AA027700 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2019 to 2023
$2.4M
Pivotal role of thalamic hypocretin transmission during EtOH seeking and relapseR01AA026999 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARTIN-FARDON, REMI · 2018 to 2022
$2.2M
Synaptic Mechanisms underlying sex-differences in alcohol use disorderR01AA029841 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARISA ROBERTO · 2022 to 2026
$2.0M
Gene-environment interaction: the brain CRF system in alcohol preferring msP ratsR01AA017447 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2009 to 2013
$1.8M
NIAAA NIH HHS K99 AA030609NIAAA NIH HHS K99 AA031718NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA012404NIAAA NIH HHS R01 AA017447NIAAA NIH HHS R01 AA021491NIAAA NIH HHS R01 AA026999NIAAA NIH HHS R01 AA027700NIAAA NIH HHS R01 AA028549NIAAA NIH HHS R01 AA029841NIAAA NIH HHS R37 AA017447NIAAA NIH HHS T32 AA007456NIAAA NIH HHS U01 AA013498NIAAA NIH HHS U01 AA020926NIDA NIH HHS R21 DA053443
6 · The paper itself

Abstract

backgroundAlcohol use disorder (AUD) is a chronic relapsing disorder and a leading preventable cause of death worldwide. The central nucleus of the amygdala (CeA) is a hub for stress and AUD. Norepinephrine (NE), also known as noradrenaline, regulates the brain's response to stress and alcohol. We previously reported that α

methodsHere, we determined that alcohol dependence and withdrawal alter the CeA noradrenergic system in female rats using ex vivo electrophysiology, in situ hybridization, and site-specific behavioral pharmacology. We also analyzed RNA-sequencing data from postmortem CeA samples obtained from female donors with and without AUD.

resultsNE bidirectionally (increase and decrease) modulated CeA GABAergic (gamma-aminobutyric acidergic) transmission via both α

conclusionsAmygdalar α

Indexed as

Alcohol DrinkingAlcoholismCentral Amygdaloid Nucleusgamma-Aminobutyric AcidNorepinephrineSynaptic TransmissionAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-AntagonistsAnimalsEthanolFemalePrazosinPropranololRatsRats, Sprague-DawleyAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-AntagonistsEthanolgamma-Aminobutyric AcidNorepinephrinePrazosinPropranololAdrenergic receptorAlcoholNorepinephrine/noradrenalinePrazosinPropranolol

Identifiers

PMID40194754
PMCPMC12369889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.